The clinical challenge of healing wounds that are either difficult to access or exhibit delayed recovery remains a significant obstacle in healthcare. Existing biomaterials designed for tissue engineering often require surgical implantation, which introduces risks and patient discomfort. Furthermore, many lack the necessary mechanical compliance to adapt dynamically to soft and irregular tissue structures. The Terasaki team’s newly developed hydrogel addresses these shortcomings by harnessing the intrinsic properties of silk fibroin—an extensively biocompatible protein harvested from silkworm cocoons—and puerarin, a bioactive isoflavone extracted from the kudzu plant root known for its potent antioxidant and anti-inflammatory effects.

Through meticulous experimentation, the researchers synthesized five hydrogel formulations, each varying in puerarin concentration from 1% to 5%, while maintaining a constant silk fibroin content. This systematic approach enabled them to explore how incremental adjustments in the puerarin ratio influence the hydrogel’s physicochemical properties. Published in the journal ACS Omega, their findings reveal that puerarin molecules form extensive hydrogen bonding networks within the silk fibroin matrix. This supramolecular assembly significantly enhances the structural integrity and mechanical stability of the hydrogel without perturbing the native protein conformation of silk fibroin, preserving its biological functionality.

The interplay between silk fibroin and puerarin molecules results in a hydrogel with a tunable internal architecture. Higher puerarin levels create denser polymeric networks, which confer increased viscoelastic strength to the material. Importantly, this tailored supramolecular organization facilitates the hydrogel’s injectability: it can be pushed through an ultrafine 27-gauge needle and rapidly recuperate its gel state once extruded into a biological environment. This unique shear-thinning and self-healing behavior confers an exceptional advantage for minimally invasive delivery, potentially eliminating the need for extensive surgical procedures.

In vitro biocompatibility assessments revealed that cultured human skin cells exposed to the silk fibroin-puerarin hydrogels exhibited over 95% viability from the onset of exposure. Remarkably, these cells demonstrated accelerated migration and proliferation leading to complete wound area closure within 72 hours for all tested formulations. The variant with the highest puerarin concentration achieved an unprecedented approximate 60% closure rate within the first 24 hours, underscoring puerarin’s role in expediting cellular processes essential for tissue regeneration. Crucially, no cytotoxic effects or adverse cellular responses were observed in any of the experimental groups, confirming the safety profile of the composite hydrogel.

Dr. Bruna V. Quevedo, the study’s first author and a Visiting Scholar at the Terasaki Institute, emphasized the clinical implications of their results. She highlighted that achieving full wound healing within such a short timeframe, coupled with the material’s needle injectability, marks a significant advancement toward developing real-world therapeutic platforms for soft tissue repair. Unlike traditional biomaterials that might require open surgery or present issues with conformability, this silk fibroin-puerarin hydrogel offers a versatile and patient-friendly alternative.

Further elaborating on the translational potential, Dr. Menekse Ermis Sen, a Terasaki Fellow and corresponding author, articulated the promise of injectable biomaterials in reducing patient morbidity by circumventing invasive implantation procedures. The flexibility and biocompatibility of the hydrogel mean it can conform snugly to complex wound geometries, fostering a microenvironment conducive to cellular growth and remodeling. Such properties could transform standard care practices for chronic wounds and soft tissue injuries, which currently involve prolonged healing times and risk of complications.

At the molecular level, puerarin’s dual functions as an anti-inflammatory and antioxidant agent likely contribute synergistically to the enhanced tissue repair observed. By modulating the local inflammatory response and scavenging reactive oxygen species, puerarin creates a protective niche that promotes cellular survival and matrix deposition. This multi-functional bioactivity, integrated within a mechanically robust silk fibroin scaffold, represents a sophisticated biomaterial design strategy that aligns with the principles of tissue engineering and regenerative medicine.

Despite these promising findings, the researchers acknowledge the necessity of advancing beyond laboratory studies. Preclinical evaluations in relevant animal models will be essential to validate the hydrogel’s therapeutic efficacy and biocompatibility under physiological conditions, including dynamic mechanical stresses and complex biochemical environments. Such studies will also elucidate the degradation kinetics and long-term remodeling behaviors critical for clinical translation.

The Terasaki Institute for Biomedical Innovation, which focuses on accelerating translational research by integrating biomaterials science, cellular engineering, and medical device design, envisions that this silk fibroin-puerarin hydrogel platform could serve as a foundation for customized tissue engineering solutions. By fine-tuning molecular interactions in hydrogels and exploiting natural bioactive compounds, the institute aims to develop next-generation injectable therapies that truly enhance wound healing outcomes, improve patient comfort, and reduce healthcare burdens worldwide.

The novel injectable hydrogel’s ability to mimic native extracellular matrix properties while offering facile delivery and potent therapeutic action opens new avenues for treating a spectrum of soft tissue injuries. This research underscores the transformative power of combining traditional biomaterials with phytochemicals to create multifunctional platforms that address urgent clinical needs. As the field moves forward, the convergence of molecular engineering and natural product pharmacology heralds a new era of regenerative medicine with unprecedented potential for patient care.

Subject of Research: Cells
Article Title: Injectable Silk Fibroin−Puerarin Hydrogels with Tunable Supramolecular Organization as a Potential Platform for Tissue Engineering
News Publication Date: June 22, 2026
Web References: http://dx.doi.org/10.1021/acsomega.6c02412
References: Quevedo BV, Sen ME, et al. Injectable Silk Fibroin−Puerarin Hydrogels with Tunable Supramolecular Organization as a Potential Platform for Tissue Engineering. ACS Omega. 2026 May 13; DOI: 10.1021/acsomega.6c02412
Image Credits: Terasaki Institute for Biomedical Innovation
Keywords: Bioengineering, Regenerative Medicine, Biomaterials, Silk Fibroin, Puerarin, Injectable Hydrogel, Tissue Engineering, Wound Healing, Drug Delivery, Cell Biology, Biotechnology, Materials Science

A groundbreaking comparative study recently published in the journal Applied Surface Science offers new insights into the kinetic differences of mineral growth facilitated by two prominent bioorganic coatings: zein, a natural protein derived from maize, and polydopamine (PDA), a synthetic polymer inspired by mussel adhesive proteins. The research, led by Professor Chan Hee Park at Jeonbuk National University, marks a significant step forward by dynamically monitoring the mineralization of calcium phosphate (CaP) on titanium dioxide (TiO₂) nanoparticles in real time. Such direct comparison between these coatings on identical nanoparticle systems had been notably absent in prior research.

This study employs quartz crystal microbalance (QCM) technology to achieve nanogram-scale sensitivity, effectively tracking the mass changes associated with mineral deposition on coated nanoparticle surfaces. The dual coatings, each offering distinct surface chemistries, were applied uniformly to TiO₂ nanoparticles averaging approximately 300 nanometers in diameter before immersion in simulated body fluid—a solution mimicking the ionic composition of human plasma, ideal for initiating CaP nucleation and growth.

The findings revealed a marked disparity in mineral accumulation between the two bioorganic interfaces. PDA-coated nanoparticles exhibited about 37% greater mineral mass deposition compared to their zein-coated counterparts within the experiment’s timeframe. This enhanced mineralization is attributed largely to PDA’s surface chemistry, rich in catechol and amine groups, which form strong chelation sites for calcium ions and thus catalyze nucleation and subsequent crystal growth more effectively.

Contrastingly, zein’s composition, characterized by fewer polar functional groups and the presence of hydrophobic regions, results in a less hospitable surface for ion binding. This relatively subdued mineral nucleation leads to more disordered mineral deposits and diminished overall crystal mass. The QCM data unveiled nuanced, previously unobservable kinetics that underscore the critical role of surface functionality in dictating mineralization pathways.

Moreover, electron microscopy analysis of the mineralized surfaces highlighted distinct morphological differences. PDA coatings fostered the formation of well-organized, flower-like CaP structures with pronounced petal-shaped crystals. This morphology suggests a highly directed crystal growth environment likely facilitated by the uniform binding sites on PDA’s adhesive surface. In contrast, zein coatings led to sparsely distributed mineral deposits lacking clear crystalline order, reinforcing the notion of its limited efficacy in supporting uniform mineralization.

The implications of this work are multifaceted. From a biomedical perspective, optimizing nanoparticle surface coatings to enhance mineralization rates is vital for developing implants that integrate seamlessly with bone tissue. Faster and more controlled CaP formation can accelerate healing and improve implant longevity. Beyond medicine, materials designed with tailored surface chemistries could revolutionize water purification technologies by promoting mineral capture of contaminants and could enhance biosensor sensitivity through amplified mineral interfaces.

Professor Park emphasizes the importance of real-time kinetic investigations, stating that traditional endpoint analysis methods overlook critical phases of mineral growth dynamics. By harnessing QCM capabilities, this study bridges a knowledge gap and provides a platform for rationally designing biointerfaces with precise mineralization control. Such methodologies open new vistas in engineering materials that harness biomimetic principles for both health and environmental applications.

Additionally, these findings prompt renewed scrutiny into the molecular interactions at play during mineral nucleation. PDA’s ability to engage in diverse intermolecular bonding introduces a template for functionalizing surfaces to maximize mineral uptake and organization. The study suggests that integrating synthetic bioinspired coatings with strategic chemical functionalities offers a promising direction for advancing biointerface technologies.

While both zein and PDA remain valuable coatings within biomaterial science, this direct comparative analysis underscores PDA’s superior capability in driving mineral formation on TiO₂ nanoparticle platforms. This knowledge provides a strategic advantage in selecting or engineering coating materials optimized for specific functional requirements.

Future research may explore hybrid coatings or alternative bioorganic materials that combine the environmental friendliness of natural proteins like zein with the highly reactive surface chemistry characteristic of polydopamine. Such innovations would seek to balance biocompatibility, mineralization efficiency, and sustainability.

In summary, this pioneering research from Jeonbuk National University elucidates the dynamic and differential behaviors of bioorganic coatings in promoting calcium phosphate mineralization at the nanoscale. Employing advanced real-time monitoring techniques, the study reveals critical insights into how molecular surface chemistry influences nucleation kinetics and crystal morphology, providing a foundational framework for next-generation biomaterials design across medical and environmental domains.

Subject of Research:
Biomineralization kinetics and surface chemistry effects on calcium phosphate nucleation on titanium dioxide nanoparticles coated with bioorganic films.

Article Title:
Nanogram-scale real-time monitoring of bioorganic interfaces as mineralization platforms on titanium dioxide via quartz crystal microbalance

News Publication Date:
28 February 2026

Web References:
http://dx.doi.org/10.1016/j.apsusc.2025.165183

References:
Applied Surface Science, Volume 720, Part A, 28 February 2026, DOI: 10.1016/j.apsusc.2025.165183

Image Credits:
Professor Chan Hee Park, Jeonbuk National University

Keywords:
Surface chemistry, biomineralization, calcium phosphate, titanium dioxide nanoparticles, polydopamine, zein, quartz crystal microbalance, nanogram-scale monitoring, biomaterials, tissue regeneration, crystal growth kinetics, bioorganic coatings

Soft tissue repair has long challenged biomedical engineers due to the complex mechanical and biological requirements needed to seamlessly integrate with living tissues. The Ottawa team addressed these challenges by synthesizing peptides inspired by the natural triple helix structure of collagen, the most abundant structural protein in mammals. By engineering these synthetic peptides, the researchers gained exquisite control over the chemical composition and functional behavior of their hydrogel, surpassing the limitations of current polymer-based adhesives that often trigger adverse immune reactions.

Central to this innovation is the dual mechanism of self-assembly and photoactivation. Once introduced into a buffered solution, the peptides autonomously fold and organize into supramolecular arrays that form the soft, gelatinous matrix characteristic of hydrogels. To further enhance mechanical resilience, the material undergoes a rapid light-induced chemical crosslinking process. This photoactivated step strengthens the network by forging stable covalent bonds, transforming a malleable gel into a durable yet flexible adhesive capable of conforming to intricate tissue geometries.

The hydrogel’s mechanical performance is remarkable, offering adhesion strengths comparable to widely used commercial tissue adhesives such as LiquiBand. Unlike synthetic polymer adhesives, which can persist in the body and provoke inflammation, the peptide hydrogel is fully biodegradable. Its molecular design allows enzymatic enzymes naturally present in the human body to break down the material safely over time, mitigating risks associated with long-term implantable devices and eliminating the need for subsequent removal procedures.

This biocompatibility was rigorously tested in cell culture systems, where the hydrogel demonstrated an outstanding capacity to support cell viability and promote normal cellular functions. Such cytocompatibility is crucial for any medical material intended for direct interaction with living tissues. It points to the hydrogel’s suitability not only for soft tissue bonding but also for broader applications such as regenerative scaffolds and drug delivery platforms.

The implications of this work extend beyond wound closure. According to Dr. Emilio I. Alarcón, a lead researcher and professor at the University of Ottawa Faculty of Medicine, the material’s tunability and peptide-based architecture open possibilities for developing next-generation regenerative platforms. By tailoring peptide sequences and modifying photoactivation parameters, future iterations could target diverse tissue types, including cardiac, neural, and musculoskeletal systems.

Further underscoring the material’s clinical potential, PhD candidates Alex Ross and Daniel Nguyen emphasize the importance of minimizing foreign body reactions. Ross notes that biodegradable materials eliminate complications related to removal procedures like suture extraction, while Nguyen highlights the necessity for medical adhesives to be unobtrusive and harmoniously integrate with dynamic physiological environments. Both researchers belong to the BioEngineering and Therapeutic Solutions (BEaTS) lab, which specializes in cutting-edge bioengineering technologies.

The hydrogel also exemplifies a paradigm shift in biomaterial design: moving away from synthetic polymers towards fully peptide-based constructs that harness nature’s principles at the molecular level. This biomimetic strategy not only improves safety profiles but also enhances integration with the body’s intrinsic repair mechanisms. The peptides’ collagen-like triple helices enable precise biochemical signaling and remodeling, enhancing natural tissue regeneration in situ.

Technically, the photoactivated crosslinking utilizes light of specific wavelengths to initiate rapid bond formation among peptide side chains modified with reactive groups. This ability to control gelation spatiotemporally allows surgeons to apply the hydrogel and solidify it on demand, optimizing adherence while preserving tissue viability. This level of control is critical in minimizing surgical complications and improving healing outcomes.

Looking forward, the research team envisions expanding the hydrogel’s applications into minimally invasive surgeries, organ repair, and even injectable formulations for internal wounds. Its combination of mechanical durability, biological compatibility, and modular design positions it as a transformative tool in precision medicine and personalized therapeutics.

This advancement in peptide-based hydrogels exemplifies how interdisciplinary collaboration—melding chemistry, molecular biology, and bioengineering—can converge to solve longstanding clinical challenges. The University of Ottawa’s pioneering effort marks a decisive step towards safer, more effective tissue adhesives that hold promise to improve millions of patient outcomes worldwide.

Subject of Research: Cells

Article Title: Mechanically Stable and Tunable Photoactivated Peptide-Based Hydrogels for Soft Tissue Adhesion

News Publication Date: 27-Dec-2025

Web References:
http://dx.doi.org/10.1002/adfm.202529084

Image Credits: Faculty of Medicine, University of Ottawa

Keywords: Synthetic peptides, Hydrogels, Chemical composition, Chemistry, Surgery, Biomaterials, Immunity, Organ systems, Amino acids, Nanomaterials, Cells

The use of supercritical carbon dioxide in the fabrication process allows for a unique method of preserving the intricate structure of the adipose tissue while removing unwanted lipids and cells. This technique not only enhances the biocompatibility of the allograft but also maintains the native biochemical signals necessary for cellular interactions and tissue regeneration. As a result, the bioactive properties of the ECM are preserved, fostering an environment conducive to cell attachment, proliferation, and differentiation.

Researchers meticulously prepared the adipose tissue, subjecting it to supercritical carbon dioxide, which operates in a state that combines both liquid and gas properties. This method effectively extracts lipids and cells while leaving behind a scaffold enriched with extracellular matrix proteins and growth factors. The result is a finely tuned bioactive matrix that retains the structural and functional characteristics of natural adipose tissue, making it a prime candidate for use in reconstructive surgeries and regenerative therapies.

One significant advantage of this method is the reduction of contamination risks associated with traditional processing techniques. By employing supercritical carbon dioxide, the researchers minimized microbial presence while ensuring that essential components of the ECM remained intact. The safer processing conditions not only promote the sterility of the final product but also enhance its potential for clinical applications, especially in regenerative medicine where biocompatibility is paramount.

Furthermore, the study highlights the potential for scalability in the production of these bioactive allografts. The processes involved in using supercritical carbon dioxide can be adapted for larger quantities, presenting a viable solution to meet the growing demand for donor tissues in transplantation and regenerative medicine. This scalability paves the way for future clinical trials, ultimately aiming to establish standardized practices for creating bioactive grafts.

The significance of this research cannot be overstated. As the medical community seeks better solutions for tissue repair and regeneration, biomanufacturing through environmentally friendly methods becomes increasingly vital. Supercritical carbon dioxide not only represents a greener alternative to traditional solvent-based techniques but also aligns with current trends toward sustainable practices in scientific research. This eco-conscious approach has the potential to resonate with stakeholders across the healthcare and biotechnology sectors.

Moreover, the bioactive ECM created through this method serves as a testament to the endless possibilities inherent in tissue engineering. With its ability to mimic the natural environment of human tissues, this allograft can be tailored for a variety of applications, including wound healing, orthopedic repairs, and soft tissue reconstruction. The inherent versatility of the adipose ECM opens new avenues for personalized medicine, allowing treatments to be customized according to individual patient needs.

In addition to its applications in regenerative medicine, the study also hints at potential implications in the field of aesthetics, where bioactive materials can facilitate soft tissue augmentation procedures. As patients increasingly seek natural-looking results in cosmetic surgeries, the demand for sophisticated biomaterials rises. The bioactive adipose ECM may offer a solution that meets safety and aesthetic standards, thereby enhancing patient satisfaction.

The partnership between material science and biology continues to evolve, and the implications of this study may extend into future research endeavors. By establishing a reliable and effective method for producing bioactive materials, scientists are likely to explore other forms of tissue scaffolds that leverage sCO₂ technology. The interdisciplinary collaboration involved in such advancements illustrates the importance of innovative thinking in addressing complex challenges in healthcare.

Peer-reviewed studies are crucial for validating the findings of this research. As this work progresses towards clinical applications, it will undergo rigorous testing to determine its efficacy and safety in human trials. The pathway to translating bioactive allografts from lab to clinic is fraught with challenges. However, the interdisciplinary approach demonstrated by this research team bodes well for the future of functional biomaterial development.

The equipment and techniques required for supercritical carbon dioxide processing are becoming more accessible, further facilitating the translation of these methods into clinical practice. The integration of modern technology into conventional methods of tissue processing will allow more institutions to adopt these pioneering practices, expanding the availability of bioactive grafts to those in need.

The study’s authors emphasize the importance of continued research in this area, citing the potential for new biomaterials to redefine surgical standards. With an ever-growing body of evidence supporting the advantage of bioactive materials in enhancing recovery outcomes and reducing complication rates, healthcare professionals are eagerly awaiting the results of forthcoming clinical trials.

As the journey of bioactive human adipose ECM allografts continues, collaboration among researchers, medical professionals, and biotechnologists remains vital. Forming partnerships will ensure comprehensive approaches to clinical applications and address potential issues of scalability, regulatory approval, and standard practices in tissue engineering.

Overall, this research ushers in a new era of regenerative medicine where the intricate relationship between advanced material science and biological processes can lead to revolutionary therapies. The use of supercritical carbon dioxide in producing bioactive tissues exemplifies innovation’s role in addressing complex medical challenges. The future is bright for the application of bioactive materials in enhancing human health, as new strategies and methodologies emerge to maximize their potential.

In conclusion, the advent of bioactive human adipose extracellular matrix allografts fabricated via supercritical carbon dioxide is a remarkable stride in tissue engineering. This pioneering study not only underscores the critical need for advanced biomaterials in clinical practices but also ignites excitement in the scientific community for what is yet to come.

Subject of Research: Bioactive human adipose extracellular matrix allograft fabrication using supercritical carbon dioxide

Article Title: Fabrication of a Bioactive Human Adipose Extracellular Matrix Allograft Using Supercritical Carbon Dioxide

Article References:

Salingaros, S., Jeon, J., Dong, X. et al. Fabrication of a Bioactive Human Adipose Extracellular Matrix Allograft Using Supercritical Carbon Dioxide.
Ann Biomed Eng (2026). https://doi.org/10.1007/s10439-026-04007-x

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s10439-026-04007-x

Keywords: Bioactive materials, extracellular matrix, tissue engineering, supercritical carbon dioxide, regenerative medicine, adipose tissue, grafts, biocompatibility, sustainability.